ENTITY

PhotoCure ASA (PHO NO)

14
Analysis
Health CareNorway
PhotoCure ASA develops and produces pharmaceutical photodynamic therapy products and devices. The Company utilizes light-activated drugs in the treatment of cancer and other medical conditions. PhotoCure markets Metvix, a cream for the treatment of skin disorders, and the Curelight lamp to be used with the cream. The Company works with international research centers.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x